The 2nd Subcommittee on Rare Cancers

Press Releaseopen close

Agenda

1. Expectation for Drug Development for Rare Cancers –from the Clinical Site- (Dr. Akira Kawai, a Member of the Subcommittee)
2. Clinical Development of Rare Cancers by Genome Analysis (Dr. Tatsuhiro Shibata, a Member of the Subcommittee)
3. Points to Consider and Future Plan
4. Others

List of Handouts

• Document 1 Rationale to Discuss Rare Cancers
• Document 2 Points to Consider (Chart)
• Document 3 The 1st Subcommittee Minutes Summary
• Document 4 The 1st Subcommittee Minutes Summary (Chart)
• Document 5 Lecture Materials (Dr. Akira Kawai, a Member)
• Document 6 Lecture Materials (Dr. Tatsuhiro Shibata, a Member)